Examination of human tumors for rhoA mutations
- PMID: 8302578
Examination of human tumors for rhoA mutations
Abstract
rhoA encodes a ras-related GTP-binding protein that is thought to play a role in cytoskeletal organization. Recent evidence has suggested both that rhoA could act either as a dominant oncogene, since transfection of both normal and activated rho genes confer a transformed phenotype on fibroblast cells in culture, or as a recessive tumor suppressor gene, by virtue, in part, of its chromosomal location at 3p21, a site deleted in many human malignancies. In either case, a role for rhoA in the oncogenesis of human tumors would be supported by the finding of rhoA mutations in tumors. We therefore examined human tumors and cell lines for mutations in the protein coding regions of rhoA by RNAase protection analysis. We first examined the expression of rhoA in renal cell carcinoma cell lines in which 3p21 was heterozygously deleted or retained. We found no evidence for rhoA mutations in these specimens. We also examined RNA from lung, breast, colon or ovarian tumors and also found no evidence of activating rhoA mutations. Furthermore, there was no relation between the level of rhoA mRNA expression and the presence or absence of 3p21 deletions in the renal cell carcinoma specimens. Thus, although rhoA has transforming potential in vitro, there is no evidence that it is activated by mutation in human malignancies, or that it could act as a tumor suppressor gene in tumors in which 3p21 is deleted.
Similar articles
-
The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.Cancer Res. 2000 Nov 1;60(21):6116-33. Cancer Res. 2000. PMID: 11085536
-
[Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region].Mol Biol (Mosk). 2006 Sep-Oct;40(5):865-77. Mol Biol (Mosk). 2006. PMID: 17086988 Russian.
-
An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.Cancer Res. 2003 Jan 15;63(2):404-12. Cancer Res. 2003. PMID: 12543795
-
[Genetics of renal tumors].Orv Hetil. 2001 Jul 1;142(26):1367-73. Orv Hetil. 2001. PMID: 11478032 Review. Hungarian.
-
Recessive mutations in the oncogenesis of certain solid tumors.Immunol Ser. 1990;51:145-67. Immunol Ser. 1990. PMID: 1982853 Review. No abstract available.
Cited by
-
Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.Chin J Cancer. 2012 Apr;31(4):169-77. doi: 10.5732/cjc.011.10319. Epub 2011 Dec 23. Chin J Cancer. 2012. PMID: 22200179 Free PMC article. Review.
-
Characterization of RhoA-mediated chemoresistance in gastric cancer cells.Cancer Res Treat. 2005 Aug;37(4):251-6. doi: 10.4143/crt.2005.37.4.251. Epub 2005 Aug 31. Cancer Res Treat. 2005. PMID: 19956523 Free PMC article.
-
Rac1 controls the subcellular localization of the Rho guanine nucleotide exchange factor Net1A to regulate focal adhesion formation and cell spreading.Mol Cell Biol. 2013 Feb;33(3):622-34. doi: 10.1128/MCB.00980-12. Epub 2012 Nov 26. Mol Cell Biol. 2013. PMID: 23184663 Free PMC article.
-
Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.Br J Cancer. 1998;77(1):147-52. doi: 10.1038/bjc.1998.23. Br J Cancer. 1998. PMID: 9459160 Free PMC article.
-
Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis.Clin Exp Metastasis. 2008;25(5):569-79. doi: 10.1007/s10585-008-9173-3. Epub 2008 May 7. Clin Exp Metastasis. 2008. PMID: 18461284